Mitral Regurgitation (MR) & Transcatheter MitraClip / TEERMinimally Invasive Edge-to-Edge Repair for Leaking Mitral Valves Without Open-Heart Surgery
Mitral Regurgitation allows oxygenated blood to leak backward into the lungs with every heartbeat, precipitating severe breathlessness, pulmonary hypertension, and congestive heart failure. For patients unable to tolerate open-heart surgery, percutaneous transcatheter edge-to-edge repair (TEER / MitraClip) clips the leaking valve leaflets together through a tiny vein in the groin, delivering immediate breathing relief.
Regurgitant Volume
≥ 60 mL / Beat
Clinical threshold defining severe Grade 4+ retrograde backflow into lungs
Hospital Stay
48–72 Hours
Zero cracked breastbone, walking within 24 hours
Heart Failure Admissions
47% Relative Reduction
Landmark COAPT clinical trial long-term survival outcome
Access Pathway
Femoral Vein (Groin)
Transvenous transseptal catheter approach without surgical incisions
Recognizing Hallmark Symptoms & Warning Signs
Prevalence: The most frequent valvular disorder in adults over 65, affecting >10% of elderly patients with heart failure or prior heart attacks. | Triage Level: High once symptomatic: Severe regurgitation causes progressive left ventricular dilation, irreversible heart failure, and pulmonary hypertension.
Orthopnea & Paroxysmal Nocturnal Dyspnea
EmergencyWaking abruptly in the middle of the night gasping for air; needing 3 or more pillows to prop up the torso to prevent severe lung fluid congestion.
Severe Exertional Breathlessness (Dyspnea)
Urgent EvaluationShortness of breath on minimal exertion, such as walking between rooms, climbing four steps, or speaking in continuous sentences.
Peripheral Edema (Swollen Ankles & Legs)
Early WarningNoticeable pitting swelling in both feet, ankles, and lower legs caused by secondary right-heart congestion and fluid overload.
Persistent Fatigue & Lethargy
Early WarningUnrelenting physical exhaustion caused by reduced forward stroke volume, starving vital skeletal muscles of oxygenated blood.
Primary vs. Secondary Mitral Regurgitation: Understanding the Mechanism
The mitral valve comprises two delicate leaflets (anterior and posterior) anchored to the left ventricle by fibrous cords (chordae tendineae) and papillary muscles. In Primary (Degenerative) Mitral Regurgitation, the valve leaflets themselves are structurally torn, stretched, or prolapsed (Barlow's disease or fibroelastic deficiency), preventing complete closure during ventricular systole.
In Secondary (Functional) Mitral Regurgitation, the valve leaflets are structurally normal, but the left ventricle has enlarged and dilated due to ischemic cardiomyopathy (prior heart attacks) or non-ischemic dilated cardiomyopathy. As the heart muscle stretches, the papillary muscles are pulled apart (leaflet tethering), preventing the leaflets from meeting in the middle.
The MitraClip Revolution: How TEER Avoids Open Sternotomy
Historically, patients with severe functional mitral regurgitation and weakened heart pumping function (low EF) were trapped: open-heart surgery carried a prohibitive operative risk, while medications alone could not fix the massive mechanical leak. This led to repetitive hospitalizations and early mortality.
Transcatheter Edge-to-Edge Repair (TEER) with MitraClip recreates the surgical Alfieri stitch through a catheter. Navigated through the femoral vein in the groin across the interatrial septum, a miniature cobalt-chromium clip grasps and fastens the flailing or tethered anterior and posterior leaflets together. This creates a double-orifice valve that stops the backward leak while preserving unimpeded forward blood flow.
Landmark Evidence: What the COAPT Clinical Trial Demonstrated
The landmark COAPT trial published in the New England Journal of Medicine proved that adding MitraClip to maximum guideline-directed medical therapy in patients with heart failure and severe secondary MR resulted in a 47% relative reduction in hospital admissions for heart failure and a 38% reduction in all-cause mortality over two years.
At Yashoda Medicity, Indirapuram, TEER procedures are performed under general anesthesia with continuous live 3D Transesophageal Echocardiography (TEE). Patients awaken immediately after the clip is secured, transfer to a step-down bed within 24 hours, and are discharged home within two to three days without any surgical scars on their chest.
"MitraClip has completely rewritten the prognosis for patients with heart failure and severe mitral regurgitation who were once told nothing more could be done."
Definitive Diagnostic Tests Required
- Transthoracic 2D/3D Doppler Echocardiography: Quantifies Effective Regurgitant Orifice Area (EROA ≥ 0.40 cm²), regurgitant fraction (≥50%), and vena contracta width (≥0.7 cm).
- 3D Transesophageal Echocardiography (TEE): Precision anatomical visualization of valve leaflet scallops (A2-P2 flail gap, prolapse height, or coaptation depth).
- Right Heart Catheterization: Evaluates pulmonary capillary wedge pressure (PCWP) and pulmonary vascular resistance (PVR).
- Cardiac MRI: Assesses left ventricular end-systolic dimensions (LVESD) and myocardial viability when echocardiographic acoustic windows are suboptimal.
Treatment Approaches Compared
| Approach | Ideal Suitability | Hospital Stay | Recovery Time | Dr. Manish Aggarwal's Protocol |
|---|---|---|---|---|
| Transcatheter Edge-to-Edge Repair (MitraClip / TEER) | Severe degenerative or functional MR, elderly patients (65+), prior bypass or valve surgery, low ejection fraction (EF 20–50%), or high surgical risk | 48–72 Hours | Immediate mobilization; light activity in 3–5 days | European structural heart fellowship training (Budapest), state-of-the-art 3D TEE and fusion imaging in Yashoda Medicity's hybrid cath lab |
| Open Surgical Mitral Valve Repair / Replacement | Younger patients (<60 yrs) with isolated degenerative leaflet prolapse and low surgical mortality risk | 7–10 Days in Hospital (3–4 days ICU) | 8–12 weeks for sternum bone healing | Unbiased Heart Team evaluation; seamless referral to cardiac surgical colleagues when young anatomy uniquely warrants surgical repair |
| Guideline-Directed Medical Therapy Alone | Initial optimization with diuretics, beta-blockers, and SGLT2 inhibitors for functional MR | No admission until acute heart failure decompensation | Does not repair the mechanical leaflet coaptation defect | Intensive medical optimization followed by timely TEER evaluation before irreversible pulmonary hypertension develops |
Exact Clinical Answers to High-Volume Inquiries
"Mitral regurgitation grade 3 and grade 4 treatment without surgery"
Grade 3 (moderate-to-severe) and Grade 4 (severe) Mitral Regurgitation can now be treated without open-heart surgery using Transcatheter Edge-to-Edge Repair (TEER / MitraClip). Through a tiny puncture in the femoral vein, a small clip is placed on the leaking valve leaflets under real-time 3D echocardiographic guidance. This eliminates the need for breastbone splitting, cardiac arrest, or heart-lung bypass machines.
"MitraClip procedure cost and success rate in India"
The procedural success rate of MitraClip internationally and at centers of excellence in Delhi NCR exceeds 95% in reducing regurgitation to mild or trace levels (Grade ≤1+). The overall cost is driven by the precision-engineered imported titanium-nitinol clip implant, specialized 3D TEE imaging, and quaternary hybrid cath lab facilities. Yashoda Medicity offers transparent package estimates and assistance with cashless health insurance approvals.
"Can severe mitral regurgitation cause sudden death?"
Yes. Severe untreated mitral regurgitation overloads the left atrium and left ventricle with massive volume backflow, triggering malignant ventricular arrhythmias (VT/VF), acute flash pulmonary edema, and sudden cardiac death. Once severe symptoms develop, prompt intervention is essential to prevent permanent, irreversible heart muscle failure.
Frequently Asked Questions
Who is an ideal candidate for MitraClip instead of open-heart surgery?
Patients who qualify for MitraClip typically have severe Grade 3+ or 4+ mitral regurgitation, significant symptoms of breathlessness or fatigue despite medications, and factors that make open surgery risky, such as age over 65, previous bypass surgery, reduced ejection fraction (<40%), or chronic kidney/lung disease.
Is the MitraClip permanent, and will it ever need to be replaced?
Yes, the MitraClip is permanent. Within 3 to 6 months of implantation, the heart's natural endothelial tissue completely encapsulates the clip and the leaflet edges, forming a permanent biological bridge. Long-term registries confirm clinical durability exceeding 5 to 10 years without clip detachment.
How quickly do patients experience breathing relief after MitraClip?
Most patients notice an immediate improvement in their breathing while still in the hospital, as pulmonary venous pressure drops instantly once the valve leak is sealed. Within weeks, patients report walking greater distances, sleeping flat without extra pillows, and requiring fewer diuretic water pills.
Treatments Performed by Dr. Manish Aggarwal for This Condition
TAVR / TAVI
Pinhole percutaneous aortic valve replacement for severe aortic stenosis. Performed under conscious sedation with 48-hour hospital discharge and zero surgical chest opening.
MitraClip (TEER)
Catheter-based mitral repair clipping leaky valve leaflets together under real-time 3D echocardiography. Halts congestive heart failure progression without open-heart surgery.
Radically Honest Second Opinion
Independent forensic evaluation of coronary angiograms, echocardiograms, and bypass surgery recommendations. Direct, unvarnished clinical truth on medical management vs. stenting vs. CABG.
Estimated Procedure Cost & Cashless Insurance for Mitral Regurgitation & MitraClip
Transparent cost expectations, government price ceilings (NPPA), and cashless panel empanelment at Yashoda Medicity, Indirapuram.
Transcatheter edge-to-edge repair system package, femoral venous delivery, and 48-hour recovery stay.
Cashless authorization coordinated directly with specialized medical boards and corporate insurers.
Empanelled for CGHS, ECHS, Star Health, Care Health, HDFC ERGO, ICICI Lombard, Niva Bupa & Medi Assist.
Read Full Statutory Cost Breakdown & Room PackagesDirector's Cardiac Suite · Yashoda Medicity ↗
Discuss Your Case for Mitral Regurgitation (MR) & Transcatheter MitraClip / TEER
Same-week outpatient consultations and urgent second opinions with Dr. Manish Aggarwal at Yashoda Medicity, Indirapuram. Bring your 2D Echo or Angiogram CD for an unpressured clinical review.
Registration: 26547 Delhi Medical Council, 2005 · Dedicated 24/7 Cath Lab & CCU